NasdaqCM - Nasdaq Real Time Price USD

Pro-Dex, Inc. (PDEX)

Compare
26.60 -1.45 (-5.17%)
At close: September 24 at 4:00 PM EDT
Loading Chart for PDEX
DELL
  • Previous Close 28.05
  • Open 27.74
  • Bid 25.95 x 100
  • Ask 28.48 x 100
  • Day's Range 26.50 - 28.50
  • 52 Week Range 14.51 - 29.99
  • Volume 29,847
  • Avg. Volume 13,514
  • Market Cap (intraday) 89.324M
  • Beta (5Y Monthly) 0.38
  • PE Ratio (TTM) 44.33
  • EPS (TTM) 0.60
  • Earnings Date Oct 31, 2024 - Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 30.00

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

www.pro-dex.com

146

Full Time Employees

June 30

Fiscal Year Ends

Recent News: PDEX

View More

Performance Overview: PDEX

Trailing total returns as of 9/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PDEX
51.83%
S&P 500
20.19%

1-Year Return

PDEX
68.25%
S&P 500
32.70%

3-Year Return

PDEX
0.00%
S&P 500
28.86%

5-Year Return

PDEX
68.35%
S&P 500
91.62%

Compare To: PDEX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PDEX

View More

Valuation Measures

Annual
As of 9/24/2024
  • Market Cap

    89.96M

  • Enterprise Value

    96.66M

  • Trailing P/E

    44.65

  • Forward P/E

    18.87

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.78

  • Price/Book (mrq)

    2.91

  • Enterprise Value/Revenue

    1.80

  • Enterprise Value/EBITDA

    22.21

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.95%

  • Return on Assets (ttm)

    8.60%

  • Return on Equity (ttm)

    6.81%

  • Revenue (ttm)

    53.84M

  • Net Income Avi to Common (ttm)

    2.13M

  • Diluted EPS (ttm)

    0.60

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.85M

  • Total Debt/Equity (mrq)

    43.89%

  • Levered Free Cash Flow (ttm)

    4.68M

Research Analysis: PDEX

View More

Company Insights: PDEX

Research Reports: PDEX

View More

People Also Watch